Glycemic Outcomes Persist for up to 2 Years in Very Young Children with the Omnipod® 5 Automated Insulin Delivery System.
| Autor: | DeSalvo, Daniel J., Bode, Bruce W., Forlenza, Gregory P., Laffel, Lori M., Buckingham, Bruce A., Criego, Amy B., Schoelwer, Melissa, MacLeish, Sarah A., Sherr, Jennifer L., Hansen, David W., Ly, Trang T. |
|---|---|
| Zdroj: | Diabetes Technology & Therapeutics; Jun2024, Vol. 26 Issue 6, p383-393, 11p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|